In contrast, KANK2 exhibited negative correlations with inflammation, quiescence, differentiation, metastasis, and invasion in breast cancer (BRCA), as well as with angiogenesis in renal cell carcinoma (RCC) and invasion in ovarian carcinoma (OV) (Figure 7 B-G). Here, KANK2 is linked to hereditary clear cell renal cell carcinoma.